Over 36 months, consistent use with lifestyle changes leads to 510% body weight reduction and cardiometabolic benefits, including better HbA1c, blood pressure, and cholesterol
Russian studies spanning decades suggest Epithalon can restore age-related decline in various organ systems
Early research results on bone health and the use of GLP-1s are mixed, with some randomized trials and meta-analyses suggesting neutral or modestly protective effects on bone density and fracture risk
However, this approach requires dose-optimization work to avoid redundant effects, and no human data exists to confirm safety or efficacy of combination therapy
The peptides well-characterized interaction with the actin cytoskeleton has made it a valuable research tool for studying cell migration and tissue repair mechanisms
Work with a knowledgeable healthcare provider